ATC code R07 Other respiratory system products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup R07 is part of the anatomical group R Respiratory system.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QR07.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

R07A Other respiratory system products

edit
R07AA01 Colfosceril palmitate
R07AA02 Natural phospholipids
R07AA30 Combinations

R07AB Respiratory stimulants

edit
R07AB01 Doxapram
R07AB02 Nikethamide
R07AB03 Pentetrazol
R07AB04 Etamivan
R07AB05 Bemegride
R07AB06 Prethcamide
R07AB07 Almitrine
R07AB08 Dimefline
R07AB09 Mepixanox
R07AB52 Nikethamide, combinations
R07AB53 Pentetrazol, combinations
QR07AB99 Respiratory stimulants, combinations

R07AX Other respiratory system products

edit
R07AX01 Nitric oxide
R07AX02 Ivacaftor
R07AX30 Ivacaftor and lumacaftor
R07AX31 Ivacaftor and tezacaftor
R07AX32 Ivacaftor, tezacaftor and elexacaftor

References

edit
  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code R07". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QR07". WHO Collaborating Centre for Drug Statistics Methodology.